Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif

被引:30
|
作者
Romani, Bizhan [1 ]
Engelbrecht, Susan [1 ]
Glashoff, Richard H. [1 ]
机构
[1] Univ Stellenbosch, Div Med Virol, Dept Pathol, ZA-7505 Tygerberg, South Africa
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; CYTIDINE DEAMINASE APOBEC3G; CELL-CYCLE ARREST; ACCESSORY PROTEINS; VIRAL-RNA; SOCS-BOX; ENDOGENOUS RETROVIRUSES; ANTIRETROVIRAL ACTIVITY; REVERSE TRANSCRIPTION;
D O I
10.1007/s00705-009-0481-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) proteins are members of a protein family sharing the common characteristic of cytidine deaminase activity. The antiviral activity of APOBEC3G and APOBEC3F has been studied more extensively than that of the other members of this family. The antiviral activity of APOBEC3B and APOBEC3DE has also been described. Studies of other APOBEC proteins have not revealed any antiviral activities against HIV-1; however, further investigation is required. In the absence of human immunodeficiency virus type 1 (HIV-1) virion infectivity factor (Vif), APOBEC3G and APOBEC3F are incorporated into HIV-1 virions and hypermutate the viral genomic DNA by their cytidine deaminase activity. HIV-1 Vif protein suppresses the antiviral role of APOBEC proteins by several mechanisms that lead to inhibition of incorporation of APOBEC3G/3F into HIV-1 virions. The detailed mechanisms involved in the suppression of APOBEC proteins by Vif are still being elucidated. Novel studies in which as yet undefined aspects of the suppression of APOBEC proteins are investigated could reveal important and potentially exploitable information for addressing HIV-1 infection in humans.
引用
收藏
页码:1579 / 1588
页数:10
相关论文
共 50 条
  • [31] The Activity Spectrum of Vif from Multiple HIV-1 Subtypes against APOBEC3G, APOBEC3F, and APOBEC3H
    Binka, Mawuena
    Ooms, Marcel
    Steward, Myeika
    Simon, Viviana
    JOURNAL OF VIROLOGY, 2012, 86 (01) : 49 - 59
  • [32] Determinants of Efficient Degradation of APOBEC3 Restriction Factors by HIV-1 Vif
    Baig, Tayyba T.
    Feng, Yuqing
    Chelico, Linda
    JOURNAL OF VIROLOGY, 2014, 88 (24) : 14380 - 14395
  • [33] Polyubiquitination of APOBEC3G Is Essential for Its Degradation by HIV-1 Vif
    Shao, Qiujia
    Wang, Yudi
    Hildreth, James E. K.
    Liu, Bindong
    JOURNAL OF VIROLOGY, 2010, 84 (09) : 4840 - 4844
  • [34] APOBEC proteins and intrinsic resistance to HIV-1 infection
    Malim, Michael H.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2009, 364 (1517) : 675 - 687
  • [35] Multifaceted Counter-APOBEC3G Mechanisms Employed by HIV-1 Vif
    Britan-Rosich, Elena
    Nowarski, Roni
    Kotler, Moshe
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 410 (05) : 1065 - 1076
  • [36] The Structural Interface between HIV-1 Vif and Human APOBEC3H
    Ooms, Marcel
    Letko, Michael
    Simon, Viviana
    JOURNAL OF VIROLOGY, 2017, 91 (05)
  • [37] The structural basis for HIV-1 Vif antagonism of human APOBEC3G
    Li, Yen-Li
    Langley, Caroline A.
    Azumaya, Caleigh M.
    Echeverria, Ignacia
    Chesarino, Nicholas M.
    Emerman, Michael
    Cheng, Yifan
    Gross, John D.
    NATURE, 2023, 615 (7953) : 728 - +
  • [38] Expression of HIV-1 Vif and Human APOBEC3G with a Bicistronic Vector
    Yang Yishu
    Sun Xiaona
    Liu Di
    Wang Xiaoli
    Shen Sisi
    Li Zelin
    Zeng Yi
    MECHANICAL ENGINEERING AND MATERIALS SCIENCE, 2012, 108 : 141 - 145
  • [39] The APOBEC3C crystal structure and the interface for HIV-1 Vif binding
    Kitamura, Shingo
    Ode, Hirotaka
    Nakashima, Masaaki
    Imahashi, Mayumi
    Naganawa, Yuriko
    Kurosawa, Teppei
    Yokomaku, Yoshiyuki
    Yamane, Takashi
    Watanabe, Nobuhisa
    Suzuki, Atsuo
    Sugiura, Wataru
    Iwatani, Yasumasa
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2012, 19 (10) : 1005 - U53
  • [40] Host Restriction of HIV-1 by APOBEC3 and Viral Evasion Through Vif
    Niewiadomska, Anna Maria
    Yu, Xiao-Fang
    HIV INTERACTIONS WITH HOST CELL PROTEINS, 2009, 339 : 1 - 25